What is the ImageneBio, Inc. stock price forecast?

ImageneBio, Inc. is currently trading at $5.45. View real-time AI analysis on Alpha Lenz.

What is ImageneBio, Inc. insider trading activity?

View the latest insider trading data for ImageneBio, Inc. on Alpha Lenz.

What is ImageneBio, Inc.'s P/E ratio?

View ImageneBio, Inc.'s valuation metrics on Alpha Lenz.

ImageneBio, Inc.

NASDAQ · IMA

$5.45-0.09(-1.62%)Pre-market

Ask about ImageneBio, Inc.'s future dividend policy...

Alpha Chat Insight

“ImageneBio, Inc.'s ROE is 330.7%. Explore profitability and growth together.”

Ask for details →

Company Overview

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

CEODr. Kristin Yarema Ph.D.

Websitehttps://www.inmagenebio.com

SectorHealthcare

IndustryBiotechnology

Employees9

Company Statistics

FY 2025

Profile

N/AMarket Cap

$800.00KRevenue

0.00Shares Out

9Employees

Margins

N/AGross

-5927.25%EBITDA

-6056.38%Operating

-5712.38%Pre-Tax

-5668.63%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-53.70%ROA

330.70%ROE

-57.37%ROIC

Financial Health

$94.53MCash & Cash Equivalents

$-74.69MNet Debt

14.90%Debt/Equity

N/AInterest Cov